Patient advocate Patty Spears discusses what eligibility criteria for cancer clinical trials are, why they’re important to cancer research, and how eligibility criteria are changing to include more people with cancer in clinical trials. Read More >>
clinical trials
June 10, 2021 · Patty Spears
June 3, 2021 · ASCO Staff
The ASCO Annual Meeting begins on June 4, and here is some of the notable research that will be presented. Topics include combined immunotherapy for esophageal cancer, targeted radiation for mCRPC, olaparib for HER2-negative breast cancer, adjuvant chemotherapy for cervical cancer, pembrolizumab for kidney cancer, and toripalimab for nasopharyngeal cancer. Read More >>
June 1, 2021 · Brielle Gregory Collins, ASCO staff
As the 2021 ASCO Annual Meeting approaches, learn why the meeting is important for people diagnosed with cancer, how research from the meeting can change cancer care, and how to register in advance. Read More >>
May 20, 2021 · Brielle Gregory Collins, ASCO staff
In the latest podcast in the “Clinical Trials in Genitourinary Cancers” series, experts discuss 3 clinical trials testing new treatment options for kidney cancer, muscle-invasive bladder cancer, and metastatic castration-sensitive prostate cancer. Read More >>
May 19, 2021 · ASCO Staff
Lea los puntos destacados de la investigación temprana que acaban de publicar para la reunión anual de la American Society of Clinical Oncology (Sociedad Americana de Oncología Clínica) de 2021. Los temas incluyen la inmunoterapia para el melanoma y el cáncer de pulmón de no microcítico (NSCLC, por sus siglas en inglés), la detección del antígeno prostático específico (PSA, por sus siglas en inglés) para el cáncer de próstata, la vacunación contra el VPH y los límites de elegibilidad de los ingresos de Medicaid. Read More >>